HRES 242
116th Congress
House
Health
Congressional tributes
Drug safety, medical device, and laboratory regulation
Drug therapy
Health care costs and insurance
Health care coverage and access
Health care quality
Health promotion and preventive care
Medical research
Prescription drugs
Research and development
Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
Introduced: March 18, 2019
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 19, 2019
Referred to the Subcommittee on Health.
Mar 18, 2019
Referred to the House Committee on Energy and Commerce.
Mar 18, 2019
Introduced in House
Plain-English summary
This resolution applauds the growth in research and development into new therapies for rare diseases and recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2